hypercholesterolaemia - Robuta Search

https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/genomics-in-general-practice/disease-specific-topics/familial-hypercholesterolaemia RACGP - Familial hypercholesterolaemia General practitioners (GPs) are well placed to undertake opportunistic screening for familial hypercholesterolaemia (FH). Family screening is critical when a... racgp familial hypercholesterolaemia https://www.nice.org.uk/guidance/ta394 Overview | Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | Guidance... Evidence-based recommendations on evolocumab (Repatha) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults overview evolocumab treating primary hypercholesterolaemia https://www.mja.com.au/journal/2016/205/5/progress-care-familial-hypercholesterolaemia-2016 Progress in the care of familial hypercholesterolaemia: 2016 | The Medical Journal of Australia Significant advances have been made, but optimising models of care remains a major challenge in the care of medical journal progress https://www.nice.org.uk/guidance/ta393/chapter/1-Recommendations 1 Recommendations | Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia |... Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults 1 recommendations alirocumab treating primary https://pmc.ncbi.nlm.nih.gov/articles/PMC27432/ Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective... extent familial hypercholesterolaemia routine practice https://www.mja.com.au/journal/2005/183/4/familial-hypercholesterolaemia-look-back-look-ahead Familial hypercholesterolaemia: a look back, a look ahead | The Medical Journal of Australia Familial hypercholesterolaemia: a look back, a look ahead a look back medical journal familial hypercholesterolaemia https://pmc.ncbi.nlm.nih.gov/articles/PMC8953203/ Lactobacillus reuteri CCFM8631 Alleviates Hypercholesterolaemia Caused by the Paigen Atherogenic... Cardiovascular disease has one of the highest global incidences and mortality rates. Atherosclerosis is the main cause of cardiovascular disease, and... lactobacillus reuteri by the hypercholesterolaemia caused atherogenic https://pmc.ncbi.nlm.nih.gov/articles/PMC113765/ Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia... To assess the cost effectiveness of strategies to screen for and treat familial hypercholesterolaemia. Cost effectiveness analysis. A care pathway for each... cost effectiveness analysis different approaches screening familial https://pmc.ncbi.nlm.nih.gov/articles/PMC1884475/ Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin... Muscular problems are the major group of side-effects during statin treatment. They are known to occur much more frequently during and after exercise. For the... professional athletes suffering familial hypercholesterolaemia rarely https://www.cochrane.org/evidence/CD009518_isoflavones-hypercholesterolaemia Isoflavones for hypercholesterolaemia | Cochrane isoflavones hypercholesterolaemia cochrane https://www.nice.org.uk/guidance/ta393/chapter/the-technology 2 The technology | Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia |... Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults 2 the technology alirocumab